Cite Filings / SMMT
Feed Companies Filings Check
Sign in

CIK 0001599298 · Large accelerated filer

Summit Therapeutics Inc.

Sign in to watch
Ticker
SMMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
371979717
Phone
305-203-2034
Business address
601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
Former names
Summit Therapeutics plc, Summit Corp plc
Filings Insiders Search text
All 564 Financials 154 Shareholder Meetings 15 Executive Compensation 145 Insider Trading 130 Beneficial Ownership Interest 45 Business Combinations 128 Public Offerings 48 Foreign Private Issuers 125 Mutual Funds and ETFs 10 Others 57
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-10-19
  3. PRE 14A Proxy Proxy Statement (Preliminary) 2026-10-06
  4. DEF 14A Proxy Proxy Statement 2026-04-17
  5. PRE 14A Proxy Proxy Statement (Preliminary) 2026-04-06
  6. DEF 14A Proxy Proxy Statement 2025-04-29
  7. DEF 14A Proxy Proxy Statement 2024-04-25
  8. DEF 14A Proxy Proxy Statement 2023-09-19
  9. PRE 14A Proxy Proxy Statement (Preliminary) 2023-09-08
  10. DEF 14A Proxy Proxy Statement 2023-04-21
  11. DEF 14A Proxy Proxy Statement 2022-12-13
  12. PRE 14A Proxy Proxy Statement (Preliminary) 2022-11-29
  13. DEF 14A Proxy Proxy Statement 2022-07-06
  14. PRE 14A Proxy Proxy Statement (Preliminary) 2022-06-24
  15. DEF 14A Proxy Proxy Statement 2022-04-29
  16. DEF 14A Proxy Proxy Statement 2021-04-29

Page 1 of 1 · 15 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…